CASI Pharmeceuticals

Press Releases

About Us

A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.

Learn More

In the News

CASI's turnaround turns eastward; firm seeks to be Celgene of China

Read Article →

Poster

Annual Meeting Presentation

Download →

Poster

Corporate Presentation - BIO International Convention

Download →